Many states in the United States have approved the medicinal use of marijuana for children and adults with epilepsy. Unfortunately, few well-designed or conducted studies have been conducted on the safety or efficacy of cannabidiol in humans. However, there are safety data available on the use of compounds containing cannabidiol in adults with pain and spasticity related to multiple sclerosis.
A pooled analysis of randomized trials of Sativex (GW Pharmaceuticals, London, United Kingdom), an oromucosal spray containing cannabidiol and tetrahydrocannabinol in a 1: 1 ratio, showed no serious adverse effects. Visit More https://foodsocietyx.com/sera-labs-cbd-oil-reviews
No comments:
Post a Comment